$1.05 Billion is the total value of First Light Asset Management, LLC's 75 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 12.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORPORATION PLC | $72,087,382 | -29.6% | 1,494,039 | -0.4% | 6.85% | -14.7% |
| ATRC | Buy | ATRICURE INC | $65,236,027 | -9.6% | 1,489,407 | +1.9% | 6.20% | +9.6% |
| SIBN | Buy | SI-BONE INC | $53,611,735 | -6.0% | 2,524,093 | +19.4% | 5.09% | +13.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $51,257,435 | +13.2% | 303,137 | +45.2% | 4.87% | +37.2% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $50,862,728 | +55.1% | 2,933,260 | +62.0% | 4.83% | +87.9% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS INC | $47,088,204 | +67.8% | 1,583,329 | +1.7% | 4.47% | +103.4% |
| MODN | Buy | MODEL N INC | $46,042,581 | -30.2% | 1,886,218 | +1.1% | 4.37% | -15.4% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLC | $41,603,437 | -6.3% | 2,070,853 | +19.1% | 3.95% | +13.6% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $40,107,391 | +47.4% | 1,125,032 | +90.7% | 3.81% | +78.6% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $39,345,027 | -26.4% | 3,033,541 | +2.1% | 3.74% | -10.8% |
| NEO | Buy | NEOGENOMICS INC | $37,255,630 | -13.9% | 3,028,913 | +12.5% | 3.54% | +4.4% |
| Buy | PARAGON 28 INC | $34,360,369 | -5.9% | 2,737,878 | +33.1% | 3.26% | +14.1% | |
| TMDX | Buy | TRANSMEDICS GROUP INC | $33,840,975 | +6.8% | 618,100 | +63.8% | 3.21% | +29.4% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $29,928,864 | +103.0% | 1,440,966 | +139.9% | 2.84% | +146.1% |
| HCAT | Buy | HEALTH CATALYST INC | $29,653,057 | -6.6% | 2,930,144 | +15.3% | 2.82% | +13.2% |
| TCMD | Buy | TACTILE SYSTEMS TECHNOLOGY INC | $29,103,437 | +64.1% | 2,071,419 | +191.2% | 2.76% | +98.8% |
| OFIX | Sell | ORTHOFIX MED INC | $23,822,353 | -46.4% | 1,852,438 | -24.7% | 2.26% | -35.0% |
| PFMT | Buy | PERFORMANT FINANCIAL CORPORATION | $21,194,949 | -15.1% | 9,378,296 | +1.4% | 2.01% | +2.9% |
| XENE | Buy | XENON PHARMACEUTICALS | $20,566,711 | +57.7% | 602,070 | +77.8% | 1.95% | +91.1% |
| TELA | Buy | TELA BIO INC | $19,842,112 | +13.5% | 2,480,264 | +43.7% | 1.88% | +37.6% |
| OPRX | Buy | OPTIMIZERX CORP | $19,341,446 | -27.7% | 2,486,047 | +32.8% | 1.84% | -12.4% |
| New | STRUCTURE THERAPEUTICS INC | $18,877,853 | – | 374,412 | +100.0% | 1.79% | – | |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $18,024,229 | +14.2% | 321,173 | +2.7% | 1.71% | +38.4% |
| Buy | STEVANATO GROUP SPA | $17,378,908 | +369.7% | 584,755 | +411.7% | 1.65% | +469.3% | |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $17,020,449 | -20.4% | 848,477 | +12.0% | 1.62% | -3.5% |
| INSM | Sell | INSMED INC | $16,250,597 | +19.3% | 643,588 | -0.3% | 1.54% | +44.6% |
| KRMD | Sell | KORU MEDICAL SYSTEMS INC | $14,275,699 | -21.9% | 5,287,296 | -0.2% | 1.36% | -5.4% |
| ANAB | Buy | ANAPTYS BIO INC | $14,202,876 | +116.7% | 790,806 | +145.4% | 1.35% | +162.5% |
| OMCL | Sell | OMNICELL INC | $13,928,350 | -41.2% | 309,244 | -3.9% | 1.32% | -28.8% |
| KROS | Buy | KEROS THERAPEUTICS INC | $13,435,443 | -19.8% | 421,438 | +1.1% | 1.28% | -2.8% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $11,977,075 | -43.2% | 313,536 | -46.3% | 1.14% | -31.1% |
| OM | Buy | OUTSET MEDICAL INC | $11,112,005 | -20.3% | 1,021,324 | +60.2% | 1.06% | -3.5% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $9,767,616 | -25.5% | 305,238 | +2.1% | 0.93% | -9.7% |
| AXGN | Sell | AXOGEN INC | $9,625,660 | -46.6% | 1,925,132 | -2.5% | 0.91% | -35.3% |
| REPH | Buy | SOCIETAL CDMO INC | $9,228,230 | -37.4% | 19,676,396 | +46.8% | 0.88% | -24.1% |
| IRTC | New | IRHYTHM TECHNOLOGIES | $8,298,556 | – | 88,039 | +100.0% | 0.79% | – |
| GH | Buy | GUARDANT HEALTH | $5,891,928 | -16.8% | 198,783 | +0.5% | 0.56% | +0.9% |
| GMAB | Sell | GENMAB AS | $5,542,575 | -8.0% | 157,147 | -0.9% | 0.53% | +11.4% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $5,464,171 | +3.9% | 61,756 | +1.8% | 0.52% | +26.0% |
| Sell | MAXCYTE INC | $3,348,103 | -60.7% | 1,073,110 | -42.2% | 0.32% | -52.4% | |
| SONENDO INC | $3,121,635 | -45.2% | 4,185,619 | 0.0% | 0.30% | -33.4% | ||
| MIRO | Buy | MIROMATRIX MEDICAL INC | $2,985,058 | -23.4% | 2,278,670 | +2.4% | 0.28% | -6.9% |
| TECH | Sell | BIO TECHNE CORP | $2,238,768 | -17.3% | 32,889 | -0.9% | 0.21% | +0.5% |
| RPHM | Buy | RENEO PHARMACEUTICALS INC | $2,073,694 | +26.4% | 272,317 | +8.9% | 0.20% | +52.7% |
| SLP | Sell | SIMULATIONS PLUS INC | $1,461,866 | -4.6% | 35,057 | -0.8% | 0.14% | +15.8% |
| CUTR | Sell | CUTERA INC | $1,445,270 | -83.3% | 240,078 | -57.9% | 0.14% | -79.8% |
| HUM | HUMANA INC | $432,030 | +8.8% | 888 | 0.0% | 0.04% | +32.3% | |
| FMS | FRESENIUS MEDICAL CARE AG & CO SPONSORED ADR | $419,815 | -10.0% | 19,490 | 0.0% | 0.04% | +8.1% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $419,969 | +0.9% | 4,123 | 0.0% | 0.04% | +21.2% | |
| SNY | SANOFI-SYNTHELABO | $413,618 | -0.5% | 7,711 | 0.0% | 0.04% | +18.2% | |
| TAK | TAKEDA PHARMACEUTICAL CO | $396,496 | -1.5% | 25,630 | 0.0% | 0.04% | +18.8% | |
| EXEL | EXELIXIS INC | $403,023 | +14.3% | 18,445 | 0.0% | 0.04% | +35.7% | |
| ANTM | ELEVANCE HEALTH INC | $385,782 | -2.0% | 886 | 0.0% | 0.04% | +19.4% | |
| ENOVIS CORP | $379,814 | -17.8% | 7,203 | 0.0% | 0.04% | 0.0% | ||
| CNC | CENTENE CORPORATION | $380,286 | +2.1% | 5,521 | 0.0% | 0.04% | +24.1% | |
| SNN | SMITH & NEPHEW PLC SPONSORED ADR | $374,299 | -23.2% | 15,111 | 0.0% | 0.04% | -5.3% | |
| ABBV | New | ABBVIE | $378,612 | – | 2,540 | +100.0% | 0.04% | – |
| GLAXOSMITHKLINE PLC | $364,603 | +1.7% | 10,058 | 0.0% | 0.04% | +25.0% | ||
| GILD | GILEAD SCIENCES INC | $339,178 | -2.8% | 4,526 | 0.0% | 0.03% | +18.5% | |
| JNJ | JOHNSON & JOHNSON | $336,576 | -5.9% | 2,161 | 0.0% | 0.03% | +14.3% | |
| VTRS | VIATRIS INC | $325,479 | -1.2% | 33,010 | 0.0% | 0.03% | +19.2% | |
| MDT | MEDTRONIC PLC | $328,172 | -11.1% | 4,188 | 0.0% | 0.03% | +6.9% | |
| QUIDEL CORP | $310,931 | -11.9% | 4,257 | 0.0% | 0.03% | +7.1% | ||
| BAYRY | BAYER AG SPONSORED ADR | $305,700 | -13.2% | 25,475 | 0.0% | 0.03% | +3.6% | |
| AVTR | AVANTOR INC | $307,684 | +2.6% | 14,596 | 0.0% | 0.03% | +26.1% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $303,795 | +2.3% | 1,345 | 0.0% | 0.03% | +26.1% | |
| HCA | HCA HOLDINGS INC | $285,337 | -18.9% | 1,160 | 0.0% | 0.03% | -3.6% | |
| BIIB | BIOGEN INC | $281,683 | -9.8% | 1,096 | 0.0% | 0.03% | +12.5% | |
| QGEN | QIAGEN N.V. | $279,936 | -10.1% | 6,912 | 0.0% | 0.03% | +12.5% | |
| XRAY | DENTSPLY SIRONA INC | $281,068 | -14.6% | 8,228 | 0.0% | 0.03% | +3.8% | |
| PDCO | PATTERSON COMPANIES INC | $274,585 | -10.9% | 9,264 | 0.0% | 0.03% | +8.3% | |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $277,298 | -7.1% | 7,261 | 0.0% | 0.03% | +13.0% | |
| PKI | REVVITY INC | $246,086 | -6.8% | 2,223 | 0.0% | 0.02% | +9.5% | |
| LH | LABORATORY CORPORATION OF AMERICAN HOLDINGS | $244,879 | -16.7% | 1,218 | 0.0% | 0.02% | 0.0% | |
| OGN | ORGANON & CO | $220,750 | -16.6% | 12,716 | 0.0% | 0.02% | 0.0% | |
| SYNH | Exit | SYNEOS HEALTH INC CLASS A | $0 | – | -5,736 | -100.0% | -0.02% | – |
| Exit | AKUMIN INC | $0 | – | -1,575,098 | -100.0% | -0.02% | – | |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -160,126 | -100.0% | -0.17% | – |
| PFE | Exit | PFIZER INC | $0 | – | -140,235 | -100.0% | -0.40% | – |
| KRYS | Exit | KRYSTAL BIOTECH INC | $0 | – | -101,259 | -100.0% | -0.93% | – |
| ABCM | Exit | ABCAM PLC | $0 | – | -710,745 | -100.0% | -1.36% | – |
| RETA | Exit | REATA PHARMACEUTICALS INC | $0 | – | -1,432,208 | -100.0% | -11.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.